Tian, Ruoyu
Ge, Tian
Kweon, Hyeokmoon
Rocha, Daniel B.
Lam, Max http://orcid.org/0000-0002-4256-7844
Liu, Jimmy Z. http://orcid.org/0000-0002-8379-5480
Singh, Kritika
Levey, Daniel F. http://orcid.org/0000-0001-8431-9569
Gelernter, Joel http://orcid.org/0000-0002-4067-1859
Stein, Murray B. http://orcid.org/0000-0001-9564-2871
Tsai, Ellen A. http://orcid.org/0000-0002-5625-1189
Huang, Hailiang http://orcid.org/0000-0003-1461-5762
Chabris, Christopher F.
Lencz, Todd http://orcid.org/0000-0001-8586-338X
Runz, Heiko http://orcid.org/0000-0002-2133-7345
Chen, Chia-Yen http://orcid.org/0000-0001-9548-5597
,
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH118233, R01MH117646, R01MH118233, R01MH118233, R01MH118233)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 2 November 2023
Accepted: 2 February 2024
First Online: 26 February 2024
Competing interests
: R.T. is an employee of Dewpoint Therapeutics. E.A.T., C.-Y.C., and H.R. are employees of Biogen. J.Z.L. is an employee of GlaxoSmithKline plc. K.S. is an employee of Novartis. M.B.S. has in the past 3 years received consulting income from Acadia Pharmaceuticals, Aptinyx, atai Life Sciences, BigHealth, Biogen, Bionomics, BioXcel Therapeutics, Boehringer Ingelheim, Clexio, Delix Therapeutics, Eisai, EmpowerPharm, Engrail Therapeutics, Janssen, Jazz Pharmaceuticals, NeuroTrauma Sciences, PureTech Health, Sage Therapeutics, Sumitomo Pharma, and Roche/Genentech. M.B.S. has stock options in Oxeia Biopharmaceuticals and EpiVario. He has been paid for his editorial work on Depression and Anxiety (Editor-in-Chief), Biological Psychiatry (Deputy Editor), and UpToDate (Co-Editor-in-Chief for Psychiatry). He has also received research support from NIH, Department of Veterans Affairs, and the Department of Defense. He is on the scientific advisory board for the Brain and Behavior Research Foundation and the Anxiety and Depression Association of America. The remaining authors declare no competing interests.